Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001102624-14-001897
Filing Date
2014-11-13
Accepted
2014-11-13 19:58:16
Documents
1
Period of Report
2014-11-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4345
  Complete submission text file 0001102624-14-001897.txt   5727
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STELLAR BIOTECHNOLOGIES, INC. 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address
NIFFENEGGER KATHI (Reporting) CIK: 0001620146 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54598 | Film No.: 141220024